Health ❯ Healthcare ❯ Neurology

Cognitive Disorders

Alzheimer's Disease Dementia Mild Cognitive Impairment Alzheimer's Disease Treatments Parkinson's Disease Memory Disorders Mild Dementia Alzheimer's Assessment Tools Schizophrenia Dementia Treatments Dementia Risk Factors Early Diagnosis Dementia Management Alzheimer's Detection Memory Decline Amyloid Proteins Alzheimer's Treatment Alzheimer's Disease Research Amyloid Plaques in Alzheimer's Memory Loss Tau Pathology Dementia Treatment All-cause Dementia

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

Data suggesting that lowering tau can slow Alzheimer’s progression have prompted Biogen to plan a pivotal Phase 3 in 2027.

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

Long COVID Linked to Enlarged, Underperfused Choroid Plexus and Alzheimer’s Biomarkers

BioCog Tablet Test Sharpens Primary Care Detection of Cognitive Impairment Linked to Alzheimer’s

MRI Measure of Brain Iron Predicts Future Cognitive Decline, Radiology Study Finds

UK Launches NHS Trial of £100 Blood Test to Speed Alzheimer’s Diagnosis

Frequent Gabapentin Prescriptions Tied to Increased Dementia and Cognitive Impairment Risk

Parkinson’s Onset Side Predicts Divergent Cognitive and Mental Health Trajectories

FDA Approves First Blood Test for Alzheimer’s Diagnosis

FDA Approves First Blood Test for Early Alzheimer’s Diagnosis in Symptomatic Adults